Related Tags >> Sanofi Aflibercept Bayer Healthcare Vegf Trap

Regeneron Pharmaceuticals News

Most Popular Regeneron Pharmaceuticals Story

Sanofi: We're looking for biotech deals

November 30, 2007 — 6:59am ET

Following yesterday's investment in Regeneron, Sanofi-Aventis' Marc Cluzel (Read more...

Regeneron Pharmaceuticals Press Releases

Regeneron Announces Settlement of Patent Litigation with Genentech for U.S. Ophthalmic Sales of EYLEA™ (aflibercept) Injection
Regeneron Announces Presentation Time Change at the 2011 Deutsche Bank BioFEST
Multimedia: Regeneron Announces FDA Approval of EYLEATM (Aflibercept) Injection for the Treatment of Wet Age-Related Macular Deg
Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP in Second-line Metastatic Colorectal Cancer
Regeneron Pharmaceuticals and Bayer HealthCare Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema

Latest Headlines

Regeneron finally captures an FDA OK with new eye drug
November 21, 2011
FDA pins approval on Regeneron eye drug Eylea
November 18, 2011
Blockbuster market awaits developers of antibodies against heart attacks
November 11, 2011
Regeneron Pharmaceuticals - Biotech's Biggest Spenders 2011
November 8, 2011
Survey: Vertex, Regeneron top list of biopharma employers
September 16, 2011
Sanofi and Regeneron hit goals in RA drug study
July 13, 2011
UPDATED: Regeneron eye drug gets green flag at AdComm
June 17, 2011
What's the best strategy for working with FDA regulators?
June 15, 2011
Sanofi, Regeneron buoyed by Ph3 colon cancer success for aflibercept
April 27, 2011
Sanofi, Regeneron's aflibercept flunks PhIII trial
March 11, 2011
Regeneron scores big success with Ph3 Arcalyst gout data
February 28, 2011
J&J, AstraZeneca halt studies as safety fears spread
December 28, 2010
Safety fears trigger FDA hold for Regeneron pain med trial
December 27, 2010
Regeneron gets $10M milestone on Phase III results
December 20, 2010
Regeneron AMD drug beats Lucentis on dosing in PhIII
November 22, 2010
Regeneron inks $295M antibody discovery deal with Astellas
July 28, 2010
Ambitious Regeneron unveils mixed PhIII results for gout drug
June 9, 2010
Regeneron outlines a blockbuster future
May 12, 2010
Regeneron eye therapy looks positive in Ph2
February 18, 2010
Regeneron plots $40M expansion, 400 new hires
December 9, 2009

Paid Research Reports

More Research Reports >>